New blood thinner could make heart bypass safer during surgery
NCT ID NCT07514962
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether giving the blood thinner cangrelor through a vein during minimally invasive heart bypass surgery is safe and practical. The goal is to prevent dangerous blood clots while the patient is on the operating table. Researchers will compare 30 patients receiving cangrelor during surgery to similar patients from the past who received standard care with aspirin. The main focus is on whether cangrelor increases the risk of serious bleeding.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
cangrelor (a fast-acting blood thinner given through a vein)
What this could lead to
If successful, this could make minimally invasive heart bypass surgery safer by preventing blood clots during the procedure without increasing bleeding complications.
What could go wrong
This is a small, early-phase study with only 30 participants, so results may not apply to all patients. There is still a risk of bleeding or other complications despite careful monitoring.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Istituto Cardiocentro Ticino
RECRUITINGLugano, Ch/ti, 6900, Switzerland
Contact Phone: •••-•••-••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••